Enzo Biochem (NYSE:ENZ) Earns Sell Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ – Get Rating) in a report released on Friday. The brokerage issued a sell rating on the medical research company’s stock. Enzo Biochem Stock Performance Shares of NYSE:ENZ opened at $2.58 on Friday. Enzo Biochem has a 1 year low of $1.00 and a 1 year […]

Related Keywords

Enzo Biochem ,Enzo Biochem Inc ,Clinical Services ,Dimensional Fund Advisors ,Prudential Financial Inc ,Enzo Biochem Company Profile ,Virtu Financial ,Susquehanna International Group ,Get Rating ,International Group ,Fund Advisors ,Prudential Financial ,Enzo Biochem Daily ,Nyse Enz ,Enz ,Medical ,Initiated Coverage ,Stocknews Com ,